Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and Adolescents

NCT05260866 | Completed

• 1 other identifier: ANR-21-COVR-0010-01
• Study Type: observational
• Target: 500,000
• Locations: 1 country
• Sites: 1

Brief Summary

Mental health consequences of the COVID-19 pandemic may be vast and may potentially overwhelm the mental health system in a long-lasting manner. Evaluating the effects of the COVID-19 pandemic on mental health in vulnerable groups such as children and adolescents has become an immediate priority. The aim of this study is to evaluate the impact of COVID-19 pandemic on use of mental health resources namely 1) prescriptions of psychotropic medications and 2) mental health-related outpatient visits, hospitalizations and emergency department visits in children and adolescents in France. Secondary aim is to evaluate the impact of the pandemic on episodes of fatal and non-fatal self-harm episodes in the same population. This will be a population-based cohort study using data from healthcare claims, administrative medical and outpatient drug dispensation databases in France between January 1, 2016 and June 1, 2021. Findings will inform on the risk of upcoming outbreaks of mental disorders that can result in significant morbidity and mortality and guide timely targeted actions to improve mental health outcomes and wellbeing in the youngest.

Conditions

Mental Disorder, Child

Keywords

pediatrics; COVID 19 pandemic; mental health; psychotropic drug

Outcome Measures

Primary Outcomes (1)

• To evaluate the impact of COVID-19 pandemic on use of mental health resources

  prescriptions of psychotropic medications; mental health-related outpatient visits; mental health-related hospitalizations and emergency department visits

  1 year

Secondary Outcomes (1)

• To evaluate the impact of COVID-19 pandemic on episodes of fatal and non-fatal self-harm episodes in children and adolescents in France

  1 year

Interventions

national population-based study OTHER

No intervention

Eligibility Criteria

• Age: 6 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Children and adolescents aged from 6 to 18 years

You may qualify if:

• Children and adolescents aged from 6 to 18 years
• One dispensation of psychotropic medication or
• One mental-health related hospitalization or
• One reimbursement for an outpatient mental-health related consultation or
• One eligibility to long-term diseases corresponding to long term psychiatric diseases or
• One mental-health related cause of death using ICD-10 codes

You may not qualify if:

• none

Sponsors & Collaborators

• Assistance Publique - Hôpitaux de Paris: lead
• Agence Nationale de Recherche (ANR) National Research Agency: collaborator

Study Sites (1)

Robert Debre Hospital - Assistance Publique Hopitaux de Paris

Paris, 75019, France

Location

MeSH Terms

Conditions

Neurodevelopmental Disorders; COVID-19; Psychological Well-Being

Condition Hierarchy (Ancestors)

Mental Disorders; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Personal Satisfaction; Behavior

Study Officials

• Florentia Kaguelidou, MD, PhD

  Assistance Publique - Hôpitaux de Paris

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 17, 2022
• First Posted: March 2, 2022
• Study Start: July 1, 2021
• Primary Completion: June 30, 2022
• Study Completion: June 30, 2022
• Last Updated: February 23, 2023

Record last verified: 2022-02

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)